What are the practices that we have normalized that future generations will criticize us for? Sachin Jain, CEO of SCAN Health Plan, is perhaps the leading truth teller in health care who also runs a real health care organization. I had a really fun but serious interview with Sachin about what health care people are…
By JEFF GOLDSMITH The health policy community is obsessed with hospital mergers. In a recent paper which I critiqued, the operating thesis was that hospital mergers are conspiracies in restraint of trade, enabling hospitals to extract rent from helpless local employers and patients. This logic leads directly to advocacy (lavishly funded by Arnold Ventures philanthropy) of hospital rate…
The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated. The post FDA Will Remove Warnings for HRT Products Used for Menopause appeared first on MedCity News.
Startups in the ambient documentation space are moving beyond simple scribing to tools that can handle tasks like intake, coding and care coordination, according to Heidi Health CEO Tom Kelly. Standing out in this crowded market is a challenge, and companies’ success will hinge on creating products clinicians actually want to use, he added. The…
Excited to have finished day 1 at ISPOR Europe in Glasgow, Scotland. Come check out my session on Tuesday with Tiago Beck at 11:30-12:00pm. EU Pharmaceutical Package: Where Are We and Where Are We Going? Speakers Tiago Beck, MSc, FTI Consulting, Brussels, Belgium; Jason Shafrin, PhD, FTI Consulting, Los Angeles, CA, United States As trilogue…
RIVERSIDE, Calif. — California’s gubernatorial election is a year away, and the field of primary candidates is still taking shape. But one persistent issue has already emerged as a leading concern: the cost of health care. At a forum Nov. 7 in the Inland Empire, four Democratic candidates vying to succeed Gov. Gavin Newsom vowed…
A bipartisan vote in the Senate has led to the reopening of the government
Optain says partnership with EyePACS will allow for expanded access to retinal screening in primary care
Eli Lilly is paying $75 million up front for global rights to AAV-AIPL1, a gene therapy on track for U.S. and European regulatory submissions in the rare, inherited eye disorder Leber congenital amaurosis 4, or LCA4. The deal brings to Lilly another late-stage gene therapy for the eyes following the pharma giant’s October acquisition of…
The future of healthcare isn’t about one company “owning it all.” It’s about building the kind of ecosystem Apple unlocked with the iPhone and its App Store — one that empowers and changes the game for everyone. The post What Can Healthcare Today Learn From Apple Circa 2007? A Lot, Actually. appeared first on MedCity…